2018 American Transplant Congress » Concurrent Session: Kidney Immunosuppression: Desensitization

Date: Monday, June 4, 2018

Time: 4:30pm-6:00pm

Location: Room 4B

Session Type: Concurrent Session

Meeting: 2018 American Transplant Congress

4:30pm-4:42pm: A Follow-Up Report on the Use of IVIG+Rituximab to Reduce Donor Specific Antibodies and Improve Transplant Rates in Highly-Sensitized Patients Awaiting Deceased Donor Kidney Transplantation

R. Najjar, E. Huang, A. Vo, J. Choi, K. Lim, S. Louie, A. Peng, S. Sethi, M. Toyoda, X. Zhang, S. Jordan.

4:42pm-4:54pm: Effects of IdeS on HLA-SAB, C1q-SAB and CDC-XM

S. Järnum,¹ A. Runström,¹ L. Winstedt,¹ T. Lorant,² C. Kjellman.¹

4:54pm-5:06pm: modified DFPP Can Eliminate Donor-Reactive IgG Antibody with Preserving Fibrinogen before Kidney Transplantation

D. Iwami,¹ T. Matsumoto,² K. Hotta,¹ M. Ota,² Y. Chiba,² H. Higuchi,¹ N. Shinohara.¹

5:06pm-5:18pm: How Safe is Crossing the ABO Blood Group Barrier? A Meta-Analysis to Determine the Additive Risk of ABO-Incompatible Kidney Transplantation

A. de Weerd, M. Betjes.

5:18pm-5:30pm: Pilot Study of Plasma Cell Niche-Targeted Therapy for Enhancement of Proteasome Inhibitor Effectiveness

S. Tremblay,¹ C. Castro-Rojas,² J. Driscoll,¹ S. Knechtle,³ A. Shields,¹ R. Alloway,¹ H. Singh,² D. Hildeman,² E. Woodle.¹

5:30pm-5:42pm: Preformed Donor-Reactive T-Cells That Persist after ABO Desensitization Independently Predict Severe Acute Cellular Rejection after Living Donor Kidney Transplantation

T. Schachtner,^1,2,3 M. Stein,² P. Reinke.^1,2

5:42pm-5:54pm: Impact of the New KAS on Transplant Rates in Highly-HLA Sensitized (HS) Patients after Desenstization (DES): 3yrs Post Implementation

A. Vo, E. Huang, N. Ammerman, S. Williamson, C. Myers, A. Peng, R. Najjar, S. Sethi, K. Lim, S. Jordan.

« View all sessions from the 2018 American Transplant Congress